Skip to main navigation Skip to search Skip to main content

Icahn School of Medicine at Mount Sinai Reports Findings in Psoriasis (Deep Resolution of Clinical, Cellular and Transcriptomic Inflammatory Markers of Psoriasis Over 52 Weeks of Interleukin-17a Inhibition By Secukinumab)

Press/Media

Period5 Jun 2024

Media coverage

1

Media coverage

  • TitleIcahn School of Medicine at Mount Sinai Reports Findings in Psoriasis (Deep Resolution of Clinical, Cellular and Transcriptomic Inflammatory Markers of Psoriasis Over 52 Weeks of Interleukin-17a Inhibition By Secukinumab)
    Media name/outletImmunotherapy Daily
    Country/TerritoryUnited States
    Date5/06/24
    PersonsMayte Suarez-Farinas, Lewis Tomalin